This invention is directed to the three dimensional crystal structure of Beta-site APP Cleaving Enzyme (BACE), and to the use of this structure in rational drug design methods to identify agents that may interact with active sites of BACE. Such agents may represent new therapeutics in the treatment and/or prevention of Alzheimer's Disease.

 
Web www.patentalert.com

< Real-time gene quantification with internal standards

> STAT3 activated stem cell

> Generation of plants with altered oil content

~ 00564